Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 14Terminated 9Completed 7Withdrawn 3Active not recruiting 3Not yet recruiting 2Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 52Other hematologic neoplasm 45Plasma cell 13Gynecologic 9Head & Neck 7Gastrointestinal 7Other solid neoplasm 5Genitourinary 5Myeloid 4Dermatologic 4CNS 4Thoracic 3Sarcoma 2Classical hematology 1Breast 1

Conditions

Urinary Bladder Neoplasms 1Sarcoma, Synovial 1Ovarian Neoplasms 1Neuroblastoma 1Multiple Myeloma 1Melanoma 1Lung Neoplasms 1Esophageal Neoplasms 1Breast Neoplasms 1

Interventions

Capecitabine 88Cyclophosphamide 87Trastuzumab 81Docetaxel 81Paclitaxel 65pyrotinib 55Epirubicin 55Tamoxifen 53Letrozole 51Fulvestrant 48Vinorelbine 43Carboplatin 42Doxorubicin 41Radiotherapy 33exemestane 31Anastrozole 31Neoadjuvant Therapy 29palbociclib 27Drug Therapy 27Fluorouracil 24Bevacizumab 24pertuzumab 23Cisplatin 23eribulin 22130-nm albumin-bound paclitaxel 21Goserelin 20Gemcitabine 20Exercise 20Chemotherapy, Adjuvant 19liposomal doxorubicin 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × fludarabine × Breast × Clear all
NCT02457650 2016-08-03

T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies

Shenzhen Second People's Hospital

Phase 1 Unknown
36 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicPlasma cellSarcomaThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Melanoma, Multiple Myeloma, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Synovial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡